200
Participants
Start Date
July 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
June 30, 2027
Behavioral Treatment
Description: ARM-2-G1: Patient subjects receiving standard care services without GLP-1 medication as part of the treatment regimen, and SIPPA Health behavioral intervention/therapy. ARM-2-G2: Patient subjects receiving standard care services that includes GLP-1 medication as part of the treatment regimen, and SIPPA Health behavioral intervention/therapy.
NYC Health + Hospitals/Queens Hospital Center Diabetes Center of Excellence, Jamaica
New York City Health and Hospitals Corporation
OTHER
SIPPA Solutions INC
INDUSTRY